Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations.

Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations. Abstract Text:

    michael a sandbergMichael A Sandberg,bernard rosnerBernard Rosner,carol weigel-difrancoCarol Weigel-DiFranco,thaddeus p dryjaThaddeus P Dryja,eliot l bersonEliot L Berson,

    PURPOSE: To measure the rates of visual acuity, visual field, and ERG loss in patients with X-linked retinitis pigmentosa due to RPGR mutations and to determine whether these rates differ from those of patients with dominant retinitis pigmentosa due to RHO mutations. METHODS: Snellen visual acuities, Goldmann visual field areas (V4e white test light), and 30 Hz (cone) full-field ERG amplitudes were recorded for an average of 9.8 years in 113 patients with RPGR mutations. After censoring data to eliminate ceiling and floor effects, we used longitudinal regression to estimate mean rates of change and to compare these rates with those of a previously studied cohort of 134 patients with dominant retinitis pigmentosa due to RHO mutations, who were followed for an average of 8.9 years. Survival analysis was used to compare the age distribution of legal blindness in these two groups. To explain group differences in visual acuity, optical coherence tomograms were recorded in some patients to visualize central retinal structure. RESULTS: Mean annual exponential rates of decline for the patients with RPGR mutations were 4.0% for visual acuity, 4.7% for visual field area, and 7.1% for ERG amplitude. Each of these rates was significantly different from zero (P < 0.001). The rates of visual acuity and visual field loss were significantly faster than the corresponding rates in the RHO patients (1.6%, P < 0.001 and 2.9%, P = 0.002, respectively), whereas the rate of ERG amplitude loss was comparable to that in the RHO patients (7.7%, P = 0.39). The median age of legal blindness was 32 years younger in the RPGR patients than in the RHO patients, due primarily to loss of visual acuity rather than to loss of visual field. Loss of acuity in RPGR patients appeared to be associated with foveal thinning. CONCLUSIONS: Patients with X-linked retinitis pigmentosa due to RPGR mutations lose visual acuity and visual field more rapidly than do patients with dominant retinitis pigmentosa due to RHO mutations.

    Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations. Publishing Authors By Initials

    ma sandbergMA Sandberg,b rosnerB Rosner,c weigel-difrancoC Weigel-DiFranco,tp dryjaTP Dryja,el bersonEL Berson,

    For similar visual fields research abstracts see: visual fields research

    PUBMED ID PMID:

    MEDLINE DATE:

    Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Investigative ophthalmology & visual science

    VOLUME: 48

    Page Numbers: 1298-304

    Journal Abbreviation: Invest. Ophthalmol. Vis. Sci.

    ISSN: 0146-0404

    DAY: 3

    MONTH: Mar

    YEAR: 2007

    Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7703701

    Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations. Keywords Mesh Terms:

    KEYWORDS: Visual Fields

    MESH TERMS: physiology

    Chemical & Substance for Abstract: Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations. Information

    Substance Name: Rhodopsin

    Registry Number: 9009-81-8

    Grant and Affiliation Information for Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations.

    AFFILIATION: Berman-Gund Laboratory for the Study of Retinal Degenerations, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA. masandberg@aol.com

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NEI

    GRANT: EY14104

    ACRONYM: EY

    MEDLINETA: Invest Ophthalmol Vis Sci

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News